230 related articles for article (PubMed ID: 33576939)
1. Costs of Illness of Spinal Muscular Atrophy: A Systematic Review.
Landfeldt E; Pechmann A; McMillan HJ; Lochmüller H; Sejersen T
Appl Health Econ Health Policy; 2021 Jul; 19(4):501-520. PubMed ID: 33576939
[TBL] [Abstract][Full Text] [Related]
2. Caregiver Burden of Spinal Muscular Atrophy: A Systematic Review.
Landfeldt E; Abner S; Pechmann A; Sejersen T; McMillan HJ; Lochmüller H; Kirschner J
Pharmacoeconomics; 2023 Mar; 41(3):275-293. PubMed ID: 36515815
[TBL] [Abstract][Full Text] [Related]
3. Systematic Literature Review to Assess the Cost and Resource Use Associated with Spinal Muscular Atrophy Management.
Paracha N; Hudson P; Mitchell S; Sutherland CS
Pharmacoeconomics; 2022 Apr; 40(Suppl 1):11-38. PubMed ID: 34761360
[TBL] [Abstract][Full Text] [Related]
4. Economic Costs of Myasthenia Gravis: A Systematic Review.
Landfeldt E; Pogoryelova O; Sejersen T; Zethraeus N; Breiner A; Lochmüller H
Pharmacoeconomics; 2020 Jul; 38(7):715-728. PubMed ID: 32363541
[TBL] [Abstract][Full Text] [Related]
5. Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA).
Paracha N; Hudson P; Mitchell S; Sutherland CS
Pharmacoeconomics; 2022 Apr; 40(Suppl 1):69-89. PubMed ID: 34658008
[TBL] [Abstract][Full Text] [Related]
6. Disease burden of spinal muscular atrophy in Germany.
Klug C; Schreiber-Katz O; Thiele S; Schorling E; Zowe J; Reilich P; Walter MC; Nagels KH
Orphanet J Rare Dis; 2016 May; 11(1):58. PubMed ID: 27145956
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain.
López-Bastida J; Peña-Longobardo LM; Aranda-Reneo I; Tizzano E; Sefton M; Oliva-Moreno J
Orphanet J Rare Dis; 2017 Aug; 12(1):141. PubMed ID: 28821278
[TBL] [Abstract][Full Text] [Related]
9. Systematic literature review of the economic burden of spinal muscular atrophy and economic evaluations of treatments.
Dangouloff T; Botty C; Beaudart C; Servais L; Hiligsmann M
Orphanet J Rare Dis; 2021 Jan; 16(1):47. PubMed ID: 33485382
[TBL] [Abstract][Full Text] [Related]
10. The Economic Impact and Health-Related Quality of Life of Spinal Muscular Atrophy. An Analysis across Europe.
Peña-Longobardo LM; Aranda-Reneo I; Oliva-Moreno J; Litzkendorf S; Durand-Zaleski I; Tizzano E; López-Bastida J
Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32764338
[No Abstract] [Full Text] [Related]
11. Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in Germany.
Heinrich F; Cordts I; Günther R; Stolte B; Zeller D; Schröter C; Weyen U; Regensburger M; Wolf J; Schneider I; Hermann A; Metelmann M; Kohl Z; Linker RA; Koch JC; Radelfahr F; Schönfelder E; Gardt P; Mohajer-Peseschkian T; Osmanovic A; Klopstock T; Dorst J; Ludolph AC; Schöffski O; Boentert M; Hagenacker T; Deschauer M; Lingor P; Petri S; Schreiber-Katz O
J Neurol; 2023 Oct; 270(10):4922-4938. PubMed ID: 37356024
[TBL] [Abstract][Full Text] [Related]
12. Health Care Resource Utilization and Costs for Patients with Spinal Muscular Atrophy: Findings from a Retrospective US Claims Database Analysis.
Toro W; Yang M; Georgieva M; Song W; Patel A; Jiang AX; Zhao A; LaMarca N; Dabbous O
Adv Ther; 2023 Oct; 40(10):4589-4605. PubMed ID: 37587305
[TBL] [Abstract][Full Text] [Related]
13. Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS).
Andreas S; Chouaid C; Danson S; Siakpere O; Benjamin L; Ehness R; Dramard-Goasdoue MH; Barth J; Hoffmann H; Potter V; Barlesi F; Chirila C; Hollis K; Sweeney C; Price M; Wolowacz S; Kaye JA; Kontoudis I
Lung Cancer; 2018 Oct; 124():298-309. PubMed ID: 29961557
[TBL] [Abstract][Full Text] [Related]
14. Direct Medical Costs of Spinal Muscular Atrophy in the Catalonia Region: A Population-Based Analysis.
Darbà J
Clin Drug Investig; 2020 Apr; 40(4):335-341. PubMed ID: 32144652
[TBL] [Abstract][Full Text] [Related]
15. Prenusinersen economic and health-related quality of life burden of spinal muscular atrophy.
Chambers GM; Settumba SN; Carey KA; Cairns A; Menezes MP; Ryan M; Farrar MA
Neurology; 2020 Jul; 95(1):e1-e10. PubMed ID: 32513788
[TBL] [Abstract][Full Text] [Related]
16. Systematic Literature Review to Identify Utility Values in Patients with Spinal Muscular Atrophy (SMA) and Their Caregivers.
Sutherland CS; Hudson P; Mitchell S; Paracha N
Pharmacoeconomics; 2022 Apr; 40(Suppl 1):39-67. PubMed ID: 34907515
[TBL] [Abstract][Full Text] [Related]
17. Systematic Literature Review of Clinical and Economic Evidence for Spinal Muscular Atrophy.
Yang M; Awano H; Tanaka S; Toro W; Zhang S; Dabbous O; Igarashi A
Adv Ther; 2022 May; 39(5):1915-1958. PubMed ID: 35307799
[TBL] [Abstract][Full Text] [Related]
18. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
[TBL] [Abstract][Full Text] [Related]
19. Economic burden of spinal muscular atrophy in the United States: a contemporary assessment.
Droege M; Sproule D; Arjunji R; Gauthier-Loiselle M; Cloutier M; Dabbous O
J Med Econ; 2020 Jan; 23(1):70-79. PubMed ID: 31322019
[No Abstract] [Full Text] [Related]
20. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
